Cargando…
A 10-Week Memantine Treatment in Bipolar Depression: A Case Report. Focus on Depressive Symptomatology, Cognitive Parameters and Quality of Life
Memantine and other glutamatergic agents have been currently investigated in some off-label indications due to glutamatergic involvement in several psychoneurological disorders. We assumed that memantine similarly to ketamine may positively influence mood, moreover having a potential to improve cogn...
Autores principales: | Strzelecki, Dominik, Tabaszewska, Agnieszka, Barszcz, Zbigniew, Józefowicz, Olga, Kropiwnicki, Paweł, Rabe-Jabłońska, Jolanta |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Korean Neuropsychiatric Association
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3902162/ https://www.ncbi.nlm.nih.gov/pubmed/24474993 http://dx.doi.org/10.4306/pi.2013.10.4.421 |
Ejemplares similares
-
Memantine in neurological disorders – schizophrenia and depression
por: Czarnecka, Kamila, et al.
Publicado: (2021) -
Two grams of sarcosine in schizophrenia – is it too much? A potential role of glutamate-serotonin interaction
por: Strzelecki, Dominik, et al.
Publicado: (2014) -
Comparison of thyroid-stimulating hormone levels in adolescents with schizophrenia, bipolar disorder, unipolar depression, conduct disorders, and hyperkinetic disorders
por: Makarow-Gronert, Agnieszka, et al.
Publicado: (2021) -
Predicting depressed and elevated mood symptomatology in bipolar disorder using brain functional connectomes
por: Sankar, Anjali, et al.
Publicado: (2023) -
Decision-Making and Depressive Symptomatology
por: Leykin, Yan, et al.
Publicado: (2010)